Recent News

• 12.12.2025 - TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
• 11.17.2025 - TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
• 11.13.2025 - TELA Bio Announces Pricing of $13.0 Million Underwritten Registered Direct Offering of Common Stock and Pre-Funded Warrants
• 11.13.2025 - TELA Bio Reports Third Quarter 2025 Financial Results and Refinancing and Upsizing of Credit Facility
• 11.03.2025 - TELA Bio Appoints William Plovanic to Board of Directors

Recent Filings

• 11.17.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 11.17.2025 - 4 Statement of changes in beneficial ownership of securities
• 11.14.2025 - 424B5 Prospectus [Rule 424(b)(5)]
• 11.14.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 11.14.2025 - 8-K Current report
• 11.14.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 11.13.2025 - 424B5 Prospectus [Rule 424(b)(5)]
• 11.13.2025 - 8-K Current report
• 11.13.2025 - EX-99.1 EX-99.1
• 11.03.2025 - 8-K Current report